A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-occlusive Crisis (VOC).
Sign Up to like & getrecommendations! Published in 2022 at "Blood"
DOI: 10.1182/blood.2022015797
Abstract: The efficacy and safety of rivipansel, a predominately E-selectin antagonist, was studied in a phase 3, randomized, controlled trial for VOC requiring hospitalization (RESET). Three hundred forty-five subjects (204 adults and 141 children) were randomized… read more here.
Keywords: trial; voc; safety rivipansel; efficacy safety ... See more keywords